RARE DISEASE THERAPEUTICS
Live / Applied — Non-final action mailed (as of 31 Mar 2026)
What this means for you
Not registered yet, but its 26 Feb 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99672540
- Mark type
- Stylized text
- Filed
- 26 Feb 2026
- Attorney of record
- Stephanie Scruggs
Goods and services
- Class 042 — Scientific and technological services: Scientific research in the nature of conducting clinical trials for others in the field of pharmaceuticals; Consulting services for others in the field of design, planning, and implementation project management of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical and scientific research, namely, conducting clinical trials for others
Owner
- Rare Disease Therapeutics, Inc., Franklin, TN, US
Prosecution history
- 31 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 Mar 2026 — NON-FINAL ACTION E-MAILED
- 31 Mar 2026 — NON-FINAL ACTION WRITTEN
- 27 Mar 2026 — ASSIGNED TO EXAMINER
- 27 Mar 2026 — REQUEST FOR SPECIAL HANDLING - GRANTED
- 25 Mar 2026 — ASSIGNED TO PETITION STAFF
- 12 Mar 2026 — TEAS PETITION TO DIRECTOR-MAKE SPECIAL-RECEIVED
- 26 Feb 2026 — APPLICATION FILING RECEIPT MAILED
- 26 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 26 Feb 2026 — NEW APPLICATION ENTERED